In December 2019, the Chinese city of Wuhan was the center of origin of a pneumonialike disease outbreak with an unknown causative pathogen. The CDC, China, managed to track the source of infection to a novel coronavirus (2019-nCoV; SARS-CoV-2) that shares approximately 79.6% of its genome with SARS-CoV. The World Health Organization (WHO) initially declared COVID-19 as a Public Health Emergency of International Concern (PHEIC) and later characterized it as a global pandemic on March 11, 2020. Due to the novel nature of this virus, there is an urgent need for vaccines and therapeutics to control the spread of SARS-CoV-2 and its associated disease, COVID-19. Global efforts are underway to circumvent its further spread and treat COVID-19 patients through experimental vaccine formulations and therapeutic interventions, respectively. In the absence of any effective therapeutics, we have devised h bioinformatics-based approaches to accelerate global efforts in the fight against SARS-CoV-2 and to assist researchers in the initial phase of vaccine and therapeutics development. In this study, we have performed comprehensive meta-analyses and developed an integrative resource, "CoronaVR" (http://bioinfo.imtech.res.in/manojk/ coronavr/). Predominantly, we identified potential epitope-based vaccine candidates, siRNA-based therapeutic regimens, and diagnostic primers. The resource is categorized into the main sections "Genomes," "Epitopes," "Therapeutics," and Primers." The genome section harbors different components, viz, genomes, a genome browser, phylogenetic analysis, codon usage, glycosylation sites, and structural analysis. Under the umbrella of epitopes, subdivisions , namely cross-protective epitopes, B-cell (linear/discontinuous), T-cell (CD4 + /CD8 +), CTL, and MHC binders, are presented. The therapeutics section has different subsections like siRNA, miRNAs, and sgRNAs. Further, experimentally confirmed and designed diagnostic primers are earmarked in the primers section. Our study provided a set of shortlisted B-cell and T-cell (CD4 +

No abstract

Incorporation of rice-husk-ash (RHA), an agricultural waste, in situ during the synthesis of MIL-101(Cr) resulted in a significant improvement in the CO2 adsorption properties over the synthesized RHA-MIL-101(Cr). The newly synthesized RHA-MIL-101(Cr) composite exhibited an enhancement of 14–27% in CO2 adsorption capacity as compared to MIL-101(Cr) at 25 °C and 1 bar. The content of RHA incorporated in RHA-MIL-101(Cr) fine tuned the CO2 capture performance to achieve high working capacity (0.54 mmol g−1), high purity (78%), superior CO2/N2 selectivity (18) and low isosteric heat of adsorption (20–30 kJ mol−1). The observed superior CO2 adsorption performance of RHA-MIL-101(Cr) is attributed to the fine tuning of textural characteristics—enhancement of 12–27% in BET surface area, 12–33% in total pore volume and 18–30% in micropore volume—upon incorporation of RHA in MIL-101(Cr).

Mutual funds are considered as the best investment option because they offer a higher return with little risk. The study’s main aim is to evaluate the performance of selected large and small cap equity mutual fund schemes. The performance has been analysed in terms of return and risk using risk-adjusted performance measures. The present study is descriptive and secondary data has been collected from the website of BSE, NSE and Mutual funds. The analysis shows that “HDFC Top 100 Fund - Growth Option - Direct Plan” is top large cap mutual funds scheme and “Tata Small Cap Fund-Direct Plan-Growth” is top small cap mutual funds scheme among the selected funds as per Sharpe, Treynor and Jenson ratio.